Literature DB >> 22158907

TGF-β: the sword, the wand, and the shield of FOXP3(+) regulatory T cells.

Dat Q Tran1.   

Abstract

Since its rediscovery in the mid-1990s, FOXP3(+) regulatory T cells (Tregs) have climbed the rank to become commander-in-chief of the immune system. They possess diverse power and ability to orchestrate the immune system in time of inflammation and infection as well as in time of harmony and homeostasis. To be the commander-in-chief, they must be equipped with both offensive and defensive weaponry. This review will focus on the function of transforming growth factor-β (TGF-β) as the sword, the wand, and the shield of Tregs. Functioning as a sword, this review will begin with a discussion of the evidence that supports how Tregs utilize TGF-β to paralyze cell activation and differentiation to suppress immune response. It will next provide evidence on how TGF-β from Tregs acts as a wand to convert naïve T cells into iTregs and Th17 to aid in their combat against inflammation and infection. Lastly, the review will present evidence on the role of TGF-β produced by Tregs in providing a shield to protect and maintain Tregs against apoptosis and destabilization when surrounded by inflammation and constant stimulation. This triadic function of TGF-β empowers Tregs with the responsibility and burden to maintain homeostasis, promote immune tolerance, and regulate host defense against foreign pathogens.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22158907     DOI: 10.1093/jmcb/mjr033

Source DB:  PubMed          Journal:  J Mol Cell Biol        ISSN: 1759-4685            Impact factor:   6.216


  106 in total

1.  Successful immunotherapy induces previously unidentified allergen-specific CD4+ T-cell subsets.

Authors:  John F Ryan; Rachel Hovde; Jacob Glanville; Shu-Chen Lyu; Xuhuai Ji; Sheena Gupta; Robert J Tibshirani; David C Jay; Scott D Boyd; R Sharon Chinthrajah; Mark M Davis; Stephen J Galli; Holden T Maecker; Kari C Nadeau
Journal:  Proc Natl Acad Sci U S A       Date:  2016-01-25       Impact factor: 11.205

2.  Subconjunctival injection of in vitro transforming growth factor-β-induced regulatory T cells prolongs allogeneic corneal graft survival in mice.

Authors:  Qing Xu; Xiaobo Tan; Yingnan Zhang; Ying Jie; Zhiqiang Pan
Journal:  Int J Clin Exp Med       Date:  2015-11-15

3.  TGF-β-induced CD4+Foxp3+ T cells attenuate acute graft-versus-host disease by suppressing expansion and killing of effector CD8+ cells.

Authors:  Jian Gu; Ling Lu; Maogen Chen; Lili Xu; Qin Lan; Qiang Li; Zhongmin Liu; Guihua Chen; Ping Wang; Xuehao Wang; David Brand; Nancy Olsen; Song Guo Zheng
Journal:  J Immunol       Date:  2014-08-25       Impact factor: 5.422

4.  Active and passive immunization strategies based on the SDPM1 peptide demonstrate pre-clinical efficacy in the APPswePSEN1dE9 mouse model for Alzheimer's disease.

Authors:  Marybeth Camboni; Chiou-Miin Wang; Carlos Miranda; Jung Hae Yoon; Rui Xu; Deborah Zygmunt; Brian K Kaspar; Paul T Martin
Journal:  Neurobiol Dis       Date:  2013-09-08       Impact factor: 5.996

Review 5.  Regulatory T cells and B cells: implication on autoimmune diseases.

Authors:  Ping Wang; Song Guo Zheng
Journal:  Int J Clin Exp Pathol       Date:  2013-11-15

Review 6.  The role of all-trans retinoic acid in the biology of Foxp3+ regulatory T cells.

Authors:  Zhong-Min Liu; Kun-Peng Wang; Jilin Ma; Song Guo Zheng
Journal:  Cell Mol Immunol       Date:  2015-02-02       Impact factor: 11.530

7.  Immunization against TGF-β1 reduces collagen deposition but increases sustained inflammation in a murine asthma model.

Authors:  Yanbing Ma; Weiwei Huang; Cunbao Liu; Yang Li; Ye Xia; Xu Yang; Wenjia Sun; Hongmei Bai; Qihan Li; Zhikang Peng
Journal:  Hum Vaccin Immunother       Date:  2016-02-22       Impact factor: 3.452

Review 8.  Interleukin-35: Expanding Its Job Profile.

Authors:  Deepali V Sawant; Kristia Hamilton; Dario A A Vignali
Journal:  J Interferon Cytokine Res       Date:  2015-04-28       Impact factor: 2.607

Review 9.  Pro- and anti-inflammatory cytokines in cutaneous leishmaniasis: a review.

Authors:  Nahid Maspi; Amir Abdoli; Fathemeh Ghaffarifar
Journal:  Pathog Glob Health       Date:  2016-09-23       Impact factor: 2.894

10.  YAP Is Essential for Treg-Mediated Suppression of Antitumor Immunity.

Authors:  Xuhao Ni; Jinhui Tao; Joseph Barbi; Qian Chen; Benjamin V Park; Zhiguang Li; Nailing Zhang; Andriana Lebid; Anjali Ramaswamy; Ping Wei; Ying Zheng; Xuehong Zhang; Xingmei Wu; Paolo Vignali; Cui-Ping Yang; Huabin Li; Drew Pardoll; Ling Lu; Duojia Pan; Fan Pan
Journal:  Cancer Discov       Date:  2018-06-15       Impact factor: 39.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.